Due to the fact that at the moment there are only a few effective ways in treating liver cancer, this type of disease is of increased interest among researchers. Scientists are looking for ways to prevent liver cancer, and doctors new techniques in his treatment.
Prevention of liver cancer. The most effective way to combat this disease is its prevention at an early stage. Some scientists are working to develop vaccines, while others believe that improving the treatment of hepatitis can help prevent up to half of cases of cancer. Research on the development of a vaccine against hepatitis C is in full swing. Significant progress has been made in the treatment of chronic hepatitis.
Several new blood tests are in development, for determining their effectiveness – whether they will be able to determine the presence of tumors in the liver before ultrasound.
Developed a new technique of surgical intervention as in partial hepatectomy and liver transplant. These techniques make surgery more efficient and safe.
Additional treatment to surgery
A special activity is in the field of adjuvant therapy – postoperative treatment to reduce the likelihood of recurrence. Some studies on the use of chemotherapy or chemoembolization in the postoperative period showed low efficiency of these practices. Therefore, the researchers focused on finding new drugs targeted therapies, and antiviral drugs.
Doctors are also trying to find techniques to make a greater number of tumors was operability. Being great works in the field of neoadjuvant therapy (therapy before surgery) , including targeted therapy, chemotherapy, and radiotherapy ambulatio. Early results were encouraging.
Changes have occurred in this area, which has developed a new Toolkit ( lengthened) allowing operations through punctures. This greatly reduces blood loss, reduces pain in the postoperative period and contributes to the rapid recovery.
However, this technique is still considered experimental and its use is possible only in the presence of small tumors in certain locations of the liver.
Defining the risk of relapse after surgery.
After partial hepatectomy, one of the main concerns is the risk of relapse. To determine this factor developed a number of new genetic tests. The first results are encouraging, but require extensive research.
The main risk of the use of radiotherapy in the work on the liver tumors is that it has a negative effect on the healthy tissue of the liver. In this regard, new research in this area is aimed at focusing the radiation only to the affected areas. Modern methods of radiation Adroterapia is the most advanced in this part. We also study the possibility of brachytherapy in which catheters are placed directly on the tumor, and the emitters of radiation are inserted through these catheters. After all procedures the catheters and transducers removed.
Chemotherapy has low efficacy in liver cancer, although newer drugs in this area have been clinically tested.
Drugs such as oxaliplatin, capecitabine, gemcitabine and docetaxel was clinically tested for cancer of the liver.
Oxaliplatin showed promising results in the early stages in combination with doxorubicin and gemcitabine , and cetuximab.